During the first quarter of 2017, ADDvise had a significant growth in order intake. The order intake increased by 123,5 percent compared to last year. The total order intake was 74,0 MSEK.
ADDvise Group’s order intake amounted to a total of 74,0 MSEK during the first quarter of 2017, an increase of 123,5 percent compared to the same period last year. During the first quarter of 2016, the order intake amounted to 33,1 MSEK. The total order intake for 2016 amounted to 171,8 MSEK. The significant increase is partly due to the strong market and partly due to acquisitions.
Due to the significant growth in order intake, the company will henceforth only publish information about orders that are worth two million SEK or more. Previously, all orders worth one million SEK or more have been released.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Important information:
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on April 11, 2017 at 11:25 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.